Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings, Inc. (DNA)
:DNA
DNA Stock Chart & Stats
$8.03
-$0.35(-3.13%)
At close: 4:00 PM EST
$8.03
-$0.35(-3.13%)
Day’s Range― - ―
52-Week Range$5.00 - $17.58
Previous CloseN/A
Volume618.97K
Average Volume (3M)1.26M
Market Cap
$551.98M
Enterprise Value$763.34M
Total Cash (Recent Filing)$461.86M
Total Debt (Recent Filing)$422.87M
Price to Earnings (P/E)―
Beta2.84
Next Earnings
Mar 04, 2026EPS Estimate
-1.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.45
Shares Outstanding48,523,594
10 Day Avg. Volume1,118,233
30 Day Avg. Volume1,262,173
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.71
Price to Sales (P/S)2.24
P/FCF Ratio-1.33
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue4.23
Enterprise Value/Gross Profit5.81
Enterprise Value/Ebitda-2.35
Forecast
1Y Price Target
$14.00Price Target Upside74.35% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)-5.25
Revenue Forecast (FY)$177.07M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceGinkgo achieved its big cost-reduction target ahead of expectations, significantly reducing spending and making progress towards its goal of achieving positive EBITDA.
Revenue GrowthGinkgo delivered 120 active revenue-generating cell programs in Q2, which is an increase of 10% year over year.
Strategic ExpansionThe company is expected to potentially benefit from continued expansion into AI Tools and automation offerings.
Bears Say
Financial UnderperformanceGinkgo's third-quarter results were below consensus estimates, reflecting underperformance.
Market PerceptionShares trade at 1.1 times the 2026 CE revenue target versus the peer average of ~3 times, suggesting a less favorable market perception.
Revenue OutlookThe company lowered its biosecurity revenue outlook for the year, citing greater uncertainty with its OUS business.
Ginkgo Bioworks Holdings News
DNA FAQ
What was Ginkgo Bioworks Holdings, Inc.’s price range in the past 12 months?
Ginkgo Bioworks Holdings, Inc. lowest stock price was $5.00 and its highest was $17.58 in the past 12 months.
What is Ginkgo Bioworks Holdings, Inc.’s market cap?
Ginkgo Bioworks Holdings, Inc.’s market cap is $551.98M.
When is Ginkgo Bioworks Holdings, Inc.’s upcoming earnings report date?
Ginkgo Bioworks Holdings, Inc.’s upcoming earnings report date is Mar 04, 2026 which is in 95 days.
How were Ginkgo Bioworks Holdings, Inc.’s earnings last quarter?
Ginkgo Bioworks Holdings, Inc. released its earnings results on Nov 06, 2025. The company reported -$1.45 earnings per share for the quarter, missing the consensus estimate of -$1.241 by -$0.209.
Is Ginkgo Bioworks Holdings, Inc. overvalued?
According to Wall Street analysts Ginkgo Bioworks Holdings, Inc.’s price is currently Undervalued.
Does Ginkgo Bioworks Holdings, Inc. pay dividends?
Ginkgo Bioworks Holdings, Inc. does not currently pay dividends.
What is Ginkgo Bioworks Holdings, Inc.’s EPS estimate?
Ginkgo Bioworks Holdings, Inc.’s EPS estimate is -1.36.
How many shares outstanding does Ginkgo Bioworks Holdings, Inc. have?
Ginkgo Bioworks Holdings, Inc. has 48,523,594 shares outstanding.
What happened to Ginkgo Bioworks Holdings, Inc.’s price movement after its last earnings report?
Ginkgo Bioworks Holdings, Inc. reported an EPS of -$1.45 in its last earnings report, missing expectations of -$1.241. Following the earnings report the stock price went down -20.796%.
Which hedge fund is a major shareholder of Ginkgo Bioworks Holdings, Inc.?
Currently, no hedge funds are holding shares in DNA
Ginkgo Bioworks Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$14.00 (74.35% Upside)
$14.00 (74.35% Upside)
Blogger Sentiment
Neutral
DNA Sentiment 50%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $219.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
14.59%
12-Months-Change
Fundamentals
Return on Equity
-50.02%
Trailing 12-Months
Asset Growth
-19.70%
Trailing 12-Months
Company Description
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. is a biotechnology company that specializes in organism engineering. Founded in 2008 and headquartered in Boston, Massachusetts, Ginkgo operates in various sectors, including pharmaceuticals, agriculture, and food production. The company leverages its proprietary platform to design custom microbes for a range of applications, from producing ingredients for consumer products to optimizing agricultural outputs. Ginkgo's core services include strain development, fermentation, and bio-manufacturing, aimed at creating more sustainable and efficient solutions in biotechnology.
DNA Company Deck
DNA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in cost reductions and cash position, as well as strategic expansions and partnerships. However, these were offset by notable challenges in revenue declines and increased operating losses in the Cell Engineering segment. While the company is making strategic moves to position itself for future growth, the current financial metrics present a mixed picture.View all DNA earnings summariesDNA Revenue Breakdown
57.08% Cell Engineering
42.92% Biosecurity
DNA Stock 12 Month Forecast
Average Price Target
$14.00
▲(74.35% Upside)
Technical Analysis
Sana Biotechnology
―
Tourmaline Bio
―
Erasca
―
Rapport Therapeutics, Inc.
―
Maze Therapeutics, Inc.
―
Ownership Overview
0.99% Insiders
16.24% Mutual Funds
28.54% Other Institutional Investors
40.40% Public Companies and Individual Investors